Ovalbumin-specific T cell receptor (OVA-TCR) (OVA-TCR)

Ovalbumin-specific T cell receptors (OVA-specific TCRs) are antigen-specific receptors expressed on T lymphocytes that recognize peptides derived from the chicken egg white protein ovalbumin (OVA) in the context of Major Histocompatibility Complex (MHC) molecules (Hogquist et al., 1994; Barnden et al., 1998). These receptors are central to the OT-I and OT-II transgenic mouse models, which are the gold standards in immunology for studying CD8+ and CD4+ T cell responses, respectively. The OT-I TCR specifically recognizes the SIINFEKL peptide presented by MHC class I (H-2Kb), while the OT-II TCR recognizes the OVA 323-339 peptide presented by MHC class II (I-Ab) (Rotzschke et al., 1991). These systems allow researchers to track antigen-specific T cell activation, proliferation, and differentiation in vivo with high precision. In the pharmaceutical industry, OVA-specific TCRs are extensively used as surrogate targets to evaluate the potency and safety of novel immunotherapies, including TCR-engineered T cells (TCR-T), chimeric antigen receptor (CAR) T cells, and bispecific T-cell engagers (BiTEs). They also play a vital role in testing vaccine delivery systems and understanding the mechanisms of immune tolerance and autoimmunity.

Other names

OT-I TCROT-II TCROvalbumin-specific T-cell receptorSIINFEKL-specific TCROVA-specific T cell receptors recognizing OVA peptide–MHC complexes

The OVA-specific T cell receptor recognizes specific ovalbumin-derived peptides presented by Major Histocompatibility Complex (MHC) molecules, triggering a signaling cascade through the CD3 complex and downstream kinases like Lck and ZAP-70, which leads to T cell proliferation, cytokine production, and cytotoxic activity (Hogquist et al., 1994; PubMed: 7522125).